Niagen Bioscience (NAGE) Other Non-Current Liabilities (2011 - 2020)
Niagen Bioscience's (NAGE) quarterly Other Non-Current Liabilities came in at $250000.0 in Q2 2020, down 14.68% year-on-year from $293000.0 in Q3 2019, and up 5.04% on a QoQ basis from $238000.0 in Q1 2020.
Niagen Bioscience (NAGE) Other Non-Current Liabilities (2011 - 2020) Analysis & Trends
Niagen Bioscience (NAGE) has 8 years of Other Non-Current Liabilities data on file, last reported at $250000.0 in Q2 2020.
- On a quarterly basis, Other Non-Current Liabilities fell 14.68% year-over-year to $250000.0 in Q2 2020; TTM through Jun 2020 was $250000.0, a 14.68% decrease from a year earlier, with the FY2019 full-year figure at $169000.0, down 38.55% from the prior year.
- Other Non-Current Liabilities for Q2 2020 stood at $250000.0, up from $238000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for NAGE reached as high as $503850.0 in Q3 2017 and fell as low as $155000.0 in Q3 2018.
- Historically, Other Non-Current Liabilities has averaged $286329.8 across 5 years, with a median of $275000.0 in 2018.
- Across the five-year window, Other Non-Current Liabilities plunged 63.28% in 2018 and surged 79.7% in 2019, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $389010.0 in 2016, then declined by 19.28% to $314000.0 in 2017, then declined by 12.42% to $275000.0 in 2018, then plunged by 38.55% to $169000.0 in 2019, then surged by 47.93% to $250000.0 in 2020.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $250000.0 in Q2 2020, $238000.0 in Q1 2020, and $169000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 250,000.00 |
| Mar 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 169,000.00 |
| Sep 30, 2019 | 261,000.00 |
| Jun 30, 2019 | 293,000.00 |
| Mar 31, 2019 | 363,000.00 |
| Dec 31, 2018 | 275,000.00 |
| Sep 30, 2018 | 155,000.00 |
| Jun 30, 2018 | 185,000.00 |
| Mar 31, 2018 | 202,000.00 |
| Dec 30, 2017 | 314,000.00 |
| Sep 30, 2017 | 321,119.00 |
| Jul 1, 2017 | 503,850.00 |
| Apr 1, 2017 | 399,010.00 |
| Dec 31, 2016 | 389,010.00 |
| Oct 1, 2016 | 277,615.00 |
| Jan 2, 2016 | 272,002.00 |
| Mar 30, 2013 | 314,468.00 |
| Dec 29, 2012 | 310,267.00 |
| Sep 29, 2012 | 257,004.00 |